KDM1A and acute lymphoblastic leukemia: One of the key targets that ZEB2/LSD1 directly represses is the pro-apoptotic BCL2L11 (BIM) gene, and consequently confers a selective sensitivity of ETP-ALL to LSD1i in vivo.